Where does Blaze Bioscience, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Blaze Bioscience, Inc. ranks #31,052 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Blaze Bioscience, Inc. hold?

Blaze Bioscience, Inc. holds 8 US utility patents granted between 2021 and 2024, spanning 6 technology areas.

What is Blaze Bioscience, Inc.'s Innovation Score?

Blaze Bioscience, Inc. has an Innovation Score of 50.8 out of 100 (top 12% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Blaze Bioscience, Inc.'s patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for Blaze Bioscience, Inc..

What does claim depth mean for Blaze Bioscience, Inc.'s patents?

Blaze Bioscience, Inc.'s patents average 24.3 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Blaze Bioscience, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Blaze Bioscience, Inc.

Q: What technology areas does Blaze Bioscience, Inc. focus on?

Blaze Bioscience, Inc.'s top technology area is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations) with 8 patents. Grants appear in 6 CPC subclasses total.

USPTO PatentsView assignee record - 8 granted patents across 6 technology areas, recorded in grant years 2021–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Blaze ranks #31,052 of 49,997 tracked US assignees by granted-patent volume, with 8 patents across 6 technology areas.

#31,052
of 49,997 US assignees by volume: Top 12%
by Innovation Score (50.8/100): 24.3
avg claims per patent

USPTO PatentsView assignee plate

Corpus R31052 · US Corporation #31,052 · 8 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · SPAN-YRS · BOOK-RICH

GRANTS-MICRO 8 grants
MID-PACK #31,052/49,997
PHOTO-FINISH Black Diamond…
CPC-NARROW A61P · 6 areas
INNOV-PAR 50.8/100
CLAIMS-DENSE 24.3 claims/avg
TYPE-USCORP US Corporation
SPAN-YRS 2021–2024 · 4y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: Black Diamond Creations, LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Blaze Bioscience · this assignee

51
3D Lighting… · lowest

7

What this shows Blaze's Innovation Score is 50.8/100 (top 12% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Blaze's grants concentrate

Blaze Bioscience, Inc. is a focused PatentsView assignee: 6 CPC subclasses with 100% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2024 (3 grants) versus a trough of 1 in 2022. By volume, Blaze sits between Black Diamond Creations, LLC and Bluezone IP Holding LLC.

Blaze's three-year grant acceleration

Blaze Bioscience, Inc. shows 6 grants in 2022–2024 against only 2 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Black Diamond Cre…

8
Blackstar Enterpr…

8
Blanchette Rockef…

8
Blaser Group

8
Blee

8
Blue Gentian

8
Bluesight

8
Bluezone IP Holdi…

8
Blaze Bioscience ◀

8

What this shows Blaze holds 8 patents at rank #31,075, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Blaze

By rank, the assignees closest to #31,075 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in Blaze's primary technology class.

Blaze's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

51 Top 12% higher than 88% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2021–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2021–2019 baseline. Full figures in the table below.

View data table

Blaze Bioscience, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2021	2	25.0%
2022	1	12.5%
2023	2	25.0%
2024	3	37.5%

Which technologies does Blaze Bioscience, Inc. patent most?

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 8

C07K - Peptides 8

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 8

A61B - DIAGNOSIS; SURGERY; Identification 5

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 2

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 1

Top 6 of 6 technology areas

Where it ranks

Overall rank by patents

#31,052

of 49,997 tracked assignees

Innovation Score

50.8 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Blaze Bioscience, Inc.'s patent record in context - here's where to go next.

Blaze Bioscience, Inc.'s lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 100% of its portfolio - see every assignee active in that class. Explore A61P
Ranked #31,052 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Blaze Bioscience, Inc. against Black Diamond Creations, LLC, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 50.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.